Larvol Delta - A-FirstinHuman-Trial-to-Evaluate-the-Safety-and-Immunogenicity-of-a-G-ProteinBased-Recombinant-Respiratory-Syncytial-Virus-Vaccine-in-Healthy-Adults-1845-Years-of-Age

rRSV-G protein/CsA (BARS13) - Advaccine Biopharma

http://www.ncbi.nlm.nih.gov/pubmed/37243103

May 27, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next